Corrigendum for Tender DPRQ/PRQ No. 1194/03-09-2026 by Safe Blood Transfusion Balochistan

This corrigendum refers to the previously advertised tender DPRQ/PRQ No. 1194/03-09-2026 and TSE No. 202627091183931 issued by the Safe Blood Transfusion Balochistan. The amendment clarifies that the eligibility criterion requiring the submission of samples of quoted items along with the bid has been removed from the tender document. Samples will now be requested only from eligible bidders after the completion of the eligibility assessment. All other terms and conditions of the tender remain unchanged. Prospective bidders are advised to take note of this amendment and submit their bids accordingly. Items involved in the original tender are not listed in this corrigendum notice. Bidders should refer to the original tender documents for the full list of items. The procurement is managed by Safe Blood Transfusion Balochistan, which is responsible for ensuring the supply of medical and surgical supplies related to blood transfusion services. This amendment aims to streamline the bidding process by removing the immediate requirement for sample submission, thus reducing initial bidder burden. Eligibility criteria, including FBR registration and any required PEC categories, remain as per the original tender documents. Earnest Money and bid security requirements are also unchanged. Bidders should submit their bids by the revised deadline, which is seven days after the publication of this corrigendum, at the designated office of Safe Blood Transfusion Balochistan. It is recommended that bidders carefully review the updated tender documents and comply with all submission requirements. A practical tip for bidders is to ensure that all documentation is complete and accurate, as samples will be requested only from those who pass the initial eligibility assessment. This phased approach allows bidders to focus on documentation first before preparing samples, saving time and resources.